Hsp90 inhibitors and drug resistance in cancer: The potential benefits of combination therapies of Hsp90 inhibitors and other anti-cancer drugs
Xiangyi Lu(Wayne State University), Douglas M. Ruden(University of Southern California), Luan Wang(Wayne State University), Li Xiao(University of Alabama at Birmingham)
Cited by 114
Related Papers
A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff
|Fly|2012|12.6k
Using Drosophila melanogaster as a Model for Genotoxic Chemical Mutational Studies with a New Program, SnpSift
|Frontiers in Genetics|2012|1.2k
Ten Putative Contributors to the Obesity Epidemic
|Critical Reviews in Food Science and Nutrition|2009|701
Putative contributors to the secular increase in obesity: exploring the roads less traveled
|International Journal of Obesity|2006|623